http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108484606-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108484606-B |
| titleOfInvention | Pyrimido [4,5-f ] quinazoline compound and application thereof |
| abstract | The invention discloses a pyrimido [4,5-f ] quinazoline compound and application thereof, belonging to the field of medicines. The majority of pyrimido [4,5-f ] quinazoline compounds of the invention have the inhibitory activity of more than 70% on CDK2,4 and 6, so that the compounds of the invention have good inhibitory activity on CDK2,4 and 6, and can be used as inhibitors of CDK2,4 and 6. The compounds claimed in the present invention have strong potency and selectivity for CDK 2/4/6. Has important guiding significance for developing the medicine suitable for being used as CDK2/4/6 inhibitor. |
| priorityDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 247.